Nadia Mensali

Oslo, 0379, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Journal: Molecular pharmaceutics

Published: February 16, 2026

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Journal: Breast cancer research : BCR

Published: March 03, 2025

Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.

Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 21, 2024

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Journal: Nature communications

Published: April 17, 2022

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.

Journal: Journal for immunotherapy of cancer

Published: April 14, 2022

Emerging Biomarkers for Immunotherapy in Glioblastoma.

Emerging Biomarkers for Immunotherapy in Glioblastoma.

Journal: Cancers

Published: March 06, 2022

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.

Journal: Journal for immunotherapy of cancer

Published: September 27, 2021

Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton.

Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton.

Journal: Journal of cell science

Published: August 02, 2021

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: November 29, 2019

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation.

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation.

Journal: Case reports in immunology

Published: October 25, 2019

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: December 02, 2018

NK cells specifically TCR-dressed to kill cancer cells.

NK cells specifically TCR-dressed to kill cancer cells.

Journal: EBioMedicine

Published: November 08, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026